Search the Newsreel

ESSEX PROPERTY TRUST, INC. : JP MORGAN RAISES TARGET PRICE TO $295 FROM $275

JP Morgan has increased its target price for ESSEX PROPERTY TRUST, INC. (ESS.N) shares from $275 to $295. This update was reported by Reuters on August 14, 2026. The article itself is a brief notification of this analyst rating change.

Suratwwala Business Group consolidated net profit rises 75.23% in the June 2026 quarter

Globale Tessile reports standalone net loss of Rs 0.12 crore in the June 2026 quarter

Westerman entities (USAC) detail 9.1M-unit sale and 6.3% ownership

Westerman Interests, Inc. and Westerman, Ltd. (Westerman entities) have reported a beneficial ownership of 9,072,258 Common Units, representing 6.3% of USA Compression Partners, LP (USAC). This stake originated from the acquisition of J-W Energy Company in January 2026, and the Westerman entities recently sold …

Why (USAC) Price Action Is Critical for Tactical Trading

This article analyzes the price action of Usa Compression Partners Lp (NASDAQ: USAC) for tactical trading. It highlights a neutral near and mid-term outlook with a potentially moderating long-term positive bias, noting that support is being tested. The analysis provides specific entry, target, and …

Essex Property Trust Stock: Premium Is The Point (NYSE:ESS)

Essex Property Trust (ESS) receives a "Buy" rating due to its exceptional operational efficiency and strategic capital allocation. The company consistently achieves superior same-store NOI and operating margins, supported by strong dividend coverage and a conservative balance sheet. Its focus on coastal markets with …

A Look Inside RAM Essential Services Property Fund’s (ASX:REP) Dividend Profile, Yield and REIT Exposure

Robert Keane Sells 6,500 Shares of Cimpress (NASDAQ:CMPR) Stock

Cimpress CEO Robert Keane sold 6,500 shares of the company's stock for $624,585, reducing his direct ownership by 7.86%. The company recently reported quarterly EPS below consensus, though revenue was in line with expectations. Analysts generally maintain a "Buy" rating with a consensus price …

Fortress Biotech (FBIO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Co-Founder, President and Chief Executive Officer - Claude MaraouiChief Financial Officer - Joseph BeneschChief Operating Officer and General Counsel - Ramsey AlloushSenior Director of Corporate Operations - Jaclyn …

ADP|Automatic Data Processing Inc|Price:276.060|Chg%:+6.730

Fortress Biotech (NASDAQ: FBIO) gains $158.9M from voucher sale and boosts cash

Fortress Biotech reported a consolidated net income of $137.8 million for the first half of 2026, primarily due to a $158.9 million gain from the sale of a Rare Pediatric Disease priority review voucher by its subsidiary Cyprium. This sale significantly boosted the company's …

International Money Express jumps 35% after New York approves Western Union deal

[Western Union International Monet Transfer Banking Business Logo And Sign] martinrlee International Money Express (IMXI [https://seekingalpha.com/symbol/IMXI]) soared 35% in after-hours trading after a New York regulator approved its $500 million sale to Western Union (WU [https://seekingalpha.com/symbol/WU]). The New York Department of Financial Services approved …

Fortress Biotech earnings beat by $0.11, revenue fell short of estimates

Fortress Biotech (NASDAQ:FBIO) Posts Earnings Results, Beats Estimates By $0.12 EPS

Fortress Biotech (NASDAQ:FBIO) announced its quarterly earnings, reporting an adjusted loss of $0.08 per share, surpassing the consensus estimate by $0.12. The biopharmaceutical company also exceeded revenue forecasts with $18.72 million. Despite mixed analyst sentiment and a "Hold" consensus rating, institutional investors own a …

Xponential Fitness (XPOF) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Investor Relations - Patricia Nir Chief Executive Officer - Mike Nuzzo Interim Chief Financial Officer - Robert Julian Full Conference Call Transcript Operator: Good afternoon. Welcome to Xponential …

Here's What We Like About Essex Bio-Technology's (HKG:1061) Upcoming Dividend

PETMED EXPRESS INC 2026: Revenue $41.02M, EPS ($0.28) — 10-Q Summary

PETMED EXPRESS INC (PETS) reported Q2 2026 results with revenue of $41.02 million, a net loss of $6.15 million, and diluted loss per share of ($0.28). This reflects a 19.9% year-over-year revenue decline due to lower prescription sales and fewer new orders, although the …

MarketAxess Stock And Other Income Names Riding The Treasury Yield Revival

This article examines three stocks—MarketAxess Holdings (MKTX), WisdomTree (WT), and Northern Trust (NTRS)—that are exposed to the current environment of rising U.S. Treasury yields and increased government bond issuance. It discusses how each company stands to benefit or face challenges from these trends, highlighting …

Earnings call transcript: Midera Food Processing lifts 2026 outlook in Q2 2026

PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates

PetMed (PETS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of $0.12. This compares to a loss of $0.34 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Essex Property Trust Inc. stock underperforms Thursday when compared to competitors despite daily gains

Shares of Essex Property Trust Inc. (ESS) rose 2.18% to $287.39 on Thursday, breaking a three-day losing streak. Despite this daily gain, the stock underperformed compared to the broader market, as the S&P 500 Index increased by 0.65% and the Dow Jones Industrial Average …

Earnings call transcript: PetMed Express misses Q1 2027 estimates as shares fall

PetMed Express reported a wider-than-expected loss and significantly missed revenue forecasts for its fiscal first quarter of 2027. Despite a 19.9% year-over-year revenue decline, the company highlighted sales stabilization above $40 million for the third consecutive quarter and a substantial narrowing of its net …

PetMed Express (PETS) Stock Falls on Q1 2027 Earnings

PetMed Express (PETS) reported a challenging first quarter of fiscal 2027 with a 19.9% revenue decrease, widened operating loss, and a net loss, causing its stock to fall 6.4%. Insider trading activity shows one purchase of 25,000 shares, while hedge funds largely decreased their …

PetMed Express (PETS) grants 60,000 restricted shares to interim CEO Campbell

PetMed Express (PETS) has granted its Interim CEO and President, Leslie C.G. Campbell, 60,000 restricted shares of common stock. This award, made under the 2024 Omnibus Incentive Plan, vests fully on the first anniversary of the grant date, subject to continued employment and specific …

PetMed: Fiscal Q1 Earnings Snapshot

This article is a placeholder for an earnings snapshot for PetMed. It indicates that fiscal Q1 earnings information is expected, but the content itself is currently empty.

Fortress Biotech 2026: Revenue $17.84M, Net income ($2.48M), EPS ($0.08) — 10-Q Summary

Fortress Biotech (FBIO) reported its financial results for the quarter ended in 2026, showing product revenue of $17.84 million, an 18.9% increase year-over-year. Despite the revenue growth, the company recorded a net loss attributable to common stockholders of ($2.48 million) and a diluted loss …

Professional Diversity Network Prices $2 Million Unit Offering; Purchase and Placement Agreements Executed

Professional Diversity Network (IPDN) has priced a best efforts public offering to raise approximately $2 million in gross proceeds. The company executed a Securities Purchase Agreement with an institutional investor and a Placement Agency Agreement with Maxim Group, selling units and pre-funded units, each …

Midera Food Processing raises FY26 sales guidance to $935M-$965M

Midera Food Processing Q2 Results: Net sales up 13% YoY to $245 million

PetMed Express earnings missed by $0.40, revenue fell short of estimates

MarketAxess (MKTX) director Emily Portney records 4,170-share gift transfers

MarketAxess Holdings Inc. director Emily Hope Portney reported two bona fide gift transactions involving 4,170 shares of common stock on August 12, 2026. One transaction involved the acquisition of 2,085 shares held directly, while another involved the disposition of 2,085 shares held indirectly "By …

PetMed Express GAAP EPS of -$0.28 misses by $0.40, revenue of $41.02M

* PetMed Express press release [https://seekingalpha.com/pr/20619131-petmeds-announces-first-quarter-financial-results] (PETS [https://seekingalpha.com/symbol/PETS]): Q1 GAAP EPS of -$0.28 misses by $0.40. * Revenue of $41.02M (-19.9% Y/Y). MORE ON PETMED EXPRESS * PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript [https://seekingalpha.com/article/4911174-petmed-express-inc-pets-q4-2026-earnings-call-prepared-remarks-transcript] * PetMed Express: High-Risk Turnaround, …

Renaissance Technologies reports 5.29% PetMed Express (PETS) ownership stake in updated filing

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported a 5.29% beneficial ownership stake in PetMed Express (PETS), totaling 1,131,230 shares of common stock as of June 30, 2026. This updated filing, a Schedule 13G/A, indicates that the entities hold sole voting and …

Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Fortress Biotech reported a 14% increase in total net revenue to $18.7 million for Q2 2026 compared to Q2 2025, driven by commercial portfolio growth and advancements in partnered programs. Key highlights include Crystalys Therapeutics' $130 million Series B financing for dotinurad, expansion of …

Crystalys Raises $130M to Advance Its Once-Daily Gout Drug

Fortress Biotech (Nasdaq: FBIO) reported a 14% increase in Q2 2026 net revenue to $18.7 million, primarily driven by dermatology product sales. The company's cash and cash equivalents significantly rose to $196.6 million, aided by the monetization of a ZYCUBO® priority review voucher. Key …

Professional Diversity Network (Nasdaq: IPDN) completes $2.0M unit and warrant sale

Professional Diversity Network (Nasdaq: IPDN) has completed a public offering, selling 7,144,000 Units at $0.28 each, generating approximately $2.0 million in gross proceeds. The offering included common shares, pre-funded warrants, and common warrants, with the proceeds designated for a payment to Streeterville Capital for …